Literature DB >> 29511061

Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.

Lauren A Dalvin1, Diva R Salomão1,2, Sanjay V Patel1.   

Abstract

AIM: To determine population-based incidence of conjunctival tumours in Olmsted County, Minnesota.
METHODS: The Rochester Epidemiology Project medical record linkage system was used to identify patients with conjunctival tumours in Olmsted County (1 January 1980 to 31 December 2015). Records were reviewed for demographics, types of tumours, histopathology, treatment and clinical course. Incidence rate of all tumours was calculated per 1 000 000 person-years. Poisson regression analysis was used to assess changes in incidence over time.
RESULTS: There were 504 patients with conjunctival tumours, giving an age-adjusted and sex-adjusted incidence rate of 125 per 1 000 000 (CI 113.5 to 135.5). Incidence increased over time (P<0.001). Most tumours (474, 94%) were benign. Of benign lesions, melanocytic lesions accounted for the majority (431, 86%), with adjusted incidence rates of 10.8 (CI 7.7 to 13.9) for complexion-associated melanosis, 49.7 (CI 42.9 to 56.6) for nevus and 44.1 (37.5-50.8) for primary acquired melanosis. Malignant lesions were rare (30, 6%) with 6 cases of melanoma, 21 cases of ocular surface squamous neoplasia (OSSN), 1 case of Langerhans cell histiocytosis and 2 cases of lymphoma. Adjusted incidence rates of conjunctival melanoma and OSSN were 1.5 (CI 0.3 to 2.8) and 6.1 (CI 3.5 to 8.7), respectively. Outcomes for melanoma (mean follow-up 14 years, range 0-34) and OSSN (mean follow-up 4 years, range 0-24) were favourable in 29 cases, with one fatality due to metastatic melanoma.
CONCLUSIONS: In a population-based setting, most conjunctival tumours are benign, and the majority of lesions are melanocytic. While it is important to remain vigilant for malignancies, most conjunctival lesions in a community-based practice are not life-threatening. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  conjunctiva; epidemiology; melanoma; nevus; ocular surface squamous neoplasia; primary acquired melanosis; tumor

Mesh:

Year:  2018        PMID: 29511061      PMCID: PMC6422677          DOI: 10.1136/bjophthalmol-2017-311530

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  24 in total

1.  Epidemiology and management of ocular surface squamous neoplasia in Tanzania.

Authors:  Godfrey Furahini; Susan Lewallen
Journal:  Ophthalmic Epidemiol       Date:  2010-06       Impact factor: 1.648

2.  Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey.

Authors:  G A Lee; L W Hirst
Journal:  Arch Ophthalmol       Date:  1992-04

3.  Primary acquired melanosis of the conjunctiva: experience with 311 eyes.

Authors:  Jerry A Shields; Carol L Shields; Arman Mashayekhi; Brian P Marr; Raquel Benavides; Archana Thangappan; Laura Phan; Ralph C Eagle
Journal:  Trans Am Ophthalmol Soc       Date:  2007

4.  Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye.

Authors:  R Newton; J Ferlay; G Reeves; V Beral; D M Parkin
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.

Authors:  Ann-Cathrine Larsen
Journal:  Acta Ophthalmol       Date:  2016-05       Impact factor: 3.761

7.  Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors.

Authors:  Carol L Shields; Hakan Demirci; Ekaterina Karatza; Jerry A Shields
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

8.  The trend of ocular surface squamous neoplasia among ocular surface tumour biopsies submitted for histology from Sekuru Kaguvi Eye Unit, Harare between 1996 and 2000.

Authors:  E C Pola; R Masanganise; S Rusakaniko
Journal:  Cent Afr J Med       Date:  2003 Jan-Feb

9.  Conjunctival melanoma: is it increasing in the United States?

Authors:  Guo-Pei Yu; Dan-Nin Hu; Steven McCormick; Paul T Finger
Journal:  Am J Ophthalmol       Date:  2003-06       Impact factor: 5.258

10.  Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda.

Authors:  C Ateenyi-Agaba
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

View more
  8 in total

1.  Update on the Management of Ocular Surface Squamous Neoplasia.

Authors:  Umangi Patel; Carol L Karp; Sander R Dubovy
Journal:  Curr Ophthalmol Rep       Date:  2021-02-20

Review 2.  Ocular Surface Squamous Neoplasia Masquerading as Recalcitrant Epithelial Keratitis.

Authors:  Arjun Watane; Eric D Hansen; Luis E Vazquez; Carol L Karp
Journal:  Cornea       Date:  2022-01-26       Impact factor: 3.152

3.  Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.

Authors:  Bennett Yau-Bun Hong; Joshua R Ford; Isabella C Glitza; Carlos A Torres Cabala; Michael Tetzlaff; Victor G Prieto; Richard Parker; Claire Daniel; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 Jan-Feb 01       Impact factor: 2.011

4.  Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.

Authors:  Ann Q Tran; Nandini Venkateswaran; Anat Galor; Carol L Karp
Journal:  Eye Vis (Lond)       Date:  2019-08-27

Review 5.  Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.

Authors:  Natasha M van Poppelen; Daniël P de Bruyn; Tolga Bicer; Rob Verdijk; Nicole Naus; Hanneke Mensink; Dion Paridaens; Annelies de Klein; Erwin Brosens; Emine Kiliҫ
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

6.  Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.

Authors:  Natasha M van Poppelen; Jolique A van Ipenburg; Quincy van den Bosch; Jolanda Vaarwater; Tom Brands; Bert Eussen; Frank Magielsen; Hendrikus J Dubbink; Dion Paridaens; Erwin Brosens; Nicole Naus; Annelies de Klein; Emine Kiliç; Robert M Verdijk
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  Ocular surface squamous neoplasia in New Zealand: a ten-year review of incidence in the Waikato region.

Authors:  Ruhella R Hossain; James McKelvie
Journal:  Eye (Lond)       Date:  2021-07-14       Impact factor: 4.456

Review 8.  Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence.

Authors:  Maria Vittoria Cicinelli; Alessandro Marchese; Francesco Bandello; Giulio Modorati
Journal:  Ophthalmol Ther       Date:  2018-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.